Some analysts have predicted the market for weight-loss drugs could reach $100 billion a year by the end of the decade, with Ozempic maker Novo Nordisk and Mounjaro producer Eli Lilly leading the race. The use of GLP-1s could increase by anywhere between 10 to 70 million consumers by 2028, Goldman Sachs said on Thursday. “If GLP-1 usage ultimately increases by this amount and results in lower obesity rates, we see scope for significant spillovers to the broader economy,” Goldman economists said in a note.
Related Posts
Dodgers’ Shohei Ohtani becomes first MLB player to post 50/50 season
Dodgers superstar Shohei Ohtani hit three home runs and stole two bases Thursday to became the first player in MLB history to post a 50/50 season.
Saints’ Derek Carr reportedly fined $14,000 for Michael Jackson-esque TD celebration
New Orleans Saints QB Derek Carr has reportedly been fined $14,000 for his Michael Jackson-themed touchdown celebration.
Keyshawn shakes up his Week 3 NFL Power Rankings | All Facts No Brakes
Keyshawn Johnson breaks down his Week 3 NFL Power Rankings, giving you the inside scoop on which teams are rising to the top and which ones are slipping.